Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001752665 | SCV001997582 | uncertain significance | not provided | 2023-07-24 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Observed in individuals with ovarian or colorectal cancer (Broderick et al., 2017; Dicks et al., 2017); This variant is associated with the following publications: (PMID: 27713038, 28881617) |
Labcorp Genetics |
RCV001868524 | SCV002202760 | uncertain significance | Fanconi anemia | 2023-06-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1311682). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (rs377031191, gnomAD 0.002%). This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 23 of the FANCM protein (p.Pro23Gln). |